Primary Navigation
Want to create or adapt books like this? Learn more about how Pressbooks supports open publishing practices.
Book Contents Navigation
Land Acknowledgement
Psychoactive Substances & Society (2nd Edition)
Adopting or Adapting the Book
Instructor Materials
Acknowledgements
Jacqueline Lewis
Attributions
Accessibility Statement
Course & e-Book Introduction
1.0 Introduction
1.1 What are Psychoactive Drugs?
Jacqueline Lewis and Christine Miller
1.2 Psychoactive Drug Classifications & Effects
1.3 Legal Versus Illegal Drugs
1.4 Uses of Psychoactive Drugs
Christine Miller and Jacqueline Lewis
1.5 Learning About Psychoactive Drugs
1.6 Chapter Summary
1.7 Required Chapter Materials
1.8 Chapter Assignment
1.9 References & Media Attributions
2.0 Introduction
2.1 Demonizing Psychoactive Substances & their Use
2.2 Changing Definitions of Substance Use
2.3 Making Sense of Changing Definitions
2.4 Social Constructionist Theory
2.5 Constructing Drugs & People Who Use Drugs
2.6 Chapter Summary
2.7 Chapter Assignment
2.8 References & Media Attributions
3.0 Introduction
3.1 Understanding Social Determinants of Health
3.2 Upstream & Downstream Interventions
3.3 Social Determinants of Health & Substance Use
3.4 Disparities in Health
3.5 Primary and Secondary Prevention
3.6 Canadian Examples
3.7 Next Steps for Canada
3.8 Chapter Summary
3.9 Required Chapter Materials
3.10 Chapter Assignment
3.11 References & Media Attributions
4.0 Introduction
4.1 History of Canadian Drug Policy & Prohibition
4.2 The Temperance Movement & Alcohol Prohibition in Canada
4.3 Populations Targeted for Substance Use
4.4 Early Canadian Drug Policies
4.5 Role of Moral Reformers in Early Canadian Drug Prohibition
4.6 Chapter Summary
4.7 Chapter Assignment
4.8 References & Media Attributions
5.0 Introduction
5.1 Canadian Drug Policy
5.2 Drug Prohibition & the War on Drugs in Canada
5.3 Canadian Commissions, Committees & Task Forces on Drugs
5.4 Costs & Consequences of Current Canadian Drug Policies
5.5 Recent Canadian Drug Policy Bills
5.6 Chapter Summary
5.7 Required Chapter Materials
5.8 Chapter Assignment
5.9 References & Media Attributions
6.0 Introduction
6.1 History of International Drug Controls
6.2 The Three International Drug Conventions
6.3 Recent Changes Relating to International Drug Policy
6.4 Chapter Summary
6.5 Required Chapter Materials
6.6 Chapter Assignment
6.7 References & Media Attributions
7.0 Introduction
7.1 The War on Drugs
7.2 Drug War Costs
7.3 Impacts on Marginalized Populations
7.4 Moving Beyond Drug Criminalization
7.5 Chapter Summary
7.6 Required Chapter Materials
7.7 Chapter Assignment
7.8 References & Media Attributions
8.0 Introduction
8.1 What is Decriminalization?
8.2 Examples of Decriminalization
8.3 What is Legalization?
8.4 Examples of Legalization
8.5 Chapter Summary
8.6 Required Chapter Materials
8.7 Chapter Assignment
8.8 References & Media Attributions
9.0 Introduction
9.1 What is Stigma?
9.2 Types of Stigma
9.3 Recognizing the Impacts of Stigma
9.4 A Health Condition, not a Moral Failing
9.5 Implications of Stigmatizing Drug Policy
9.6 Person-First Language
9.7 Involving People with Lived & Living Experience (PWLLE)
9.8 Chapter Summary
9.9 Required Chapter Materials
9.10 Chapter Assignment
9.11 References & Media Attributions
10.0 Introduction
10.1 Common Misperceptions about Substances & Substance Use
10.2 What is the Meaning of Substance Use Disorder (SUD)?
10.3 Risk Factors Associated with SUDs
10.4 Impact of COVID-19 Pandemic on People Experiencing SUDs
10.5 An Approach Emphasizing Wellness & Compassionate
10.6 Chapter Summary
10.7 Required Chapter Materials
10.8 Chapter Assignment
10.9 References & Media Attributions
11.0 Introduction
11.1 What is Harm Reduction?
11.2 Harm Reduction Myths and Facts
11.3 Emergence of Harm Reduction
11.4 Key Issues in Harm Reduction
11.5 Some Recent Canadian Policy Changes
11.6 Harm Reduction Examples
11.7 Harm Reduction Benefits
11.8 Chapter Summary
11.9 Required Chapter Materials
11.10 Chapter Assignment
11.11 References & Media Attributions
12.0 Introduction
12.1 History of Canadian Medical Cannabis Policy
12.2 Cannabis Industry Growth & Regulations
12.3 Cannabis Industry Challenges
12.4 Government Response to Cannabis Industry & Regulations
12.5 Psychedelics, Medicine & Research
12.6 Evolving Psychedelics as Medicine Policies
12.7 Psychedelic Industry Growth & Challenges
12.8 Chapter Summary
12.9 Chapter Assignment
12.10 References & Media Attributions
APPENDIX A – Chapter Reviews
APPENDIX B – Materials Used With Permission
About the Authors
Previous/next navigation
Psychoactive Substances & Society (2nd Edition) Copyright © 2024 by Jacqueline Lewis & Jillian Holland-Penney is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, except where otherwise noted.